Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies.
about
Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the futureEfficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients.Managing the lipid profile of coronary heart disease patients.Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials.
P2860
Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Non-response to (statin) thera ...... rs in pharmacogenetic studies.
@ast
Non-response to (statin) thera ...... rs in pharmacogenetic studies.
@en
type
label
Non-response to (statin) thera ...... rs in pharmacogenetic studies.
@ast
Non-response to (statin) thera ...... rs in pharmacogenetic studies.
@en
prefLabel
Non-response to (statin) thera ...... rs in pharmacogenetic studies.
@ast
Non-response to (statin) thera ...... rs in pharmacogenetic studies.
@en
P2093
P2860
P1476
Non-response to (statin) thera ...... rs in pharmacogenetic studies.
@en
P2093
A J M de Craen
B M Buckley
B T Heijmans
J W Jukema
P E Slagboom
P2860
P2888
P304
P356
10.1007/S00228-015-1994-9
P577
2015-12-19T00:00:00Z